As anticipated, siRNA mediated silencing of Noxa attenuates apoptosis induction by ABT263/Crizotinib in U87 and LN229 GBM cells, establishing a key role of Noxa in this drug combination therapy (Fig. 3D). This evidence concerns the gene PMAIP1 and glioblastoma.